Overview of the SEER-Medicare Data

Joan L. Warren(American Cancer Society), Gerald F. Riley(Unknown), Peter B. Bach(CCC Diagnostics (United States)), Deborah Schrag(Dana-Farber Brigham Cancer Center), Carrie N. Klabunde(National Institutes of Health)

Medical Care

August 1, 2002

10.1097/00005650-200208001-00002

Cited by 773

Related Papers

How To Build and Interpret a Nomogram for Cancer Prognosis

|Journal of Clinical Oncology|2008|3.4k

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

|Journal of Clinical Oncology|2015|2.6k

Diagnosis and Treatment of Metastatic Colorectal Cancer

|JAMA|2021|2.6k

Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment

|JAMA|2017|2.3k

Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

|PubMed|2002|1.7k